R Scott Braithwaite
Affiliation: New York University School of Medicine
- A theoretical decision model to help inform advance directive discussions for patients with COPDNegin Hajizadeh
Yale Center for Medical Informatics, Yale University School of Medicine, New Haven, USA
BMC Med Inform Decis Mak 10:75. 2010..In order to begin to inform AD discussions between clinicians and COPD patients, we constructed a decision tree to estimate the impact of alternative AD decisions on both quality and quantity of life (quality adjusted life years, QALYs)...
- Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysisHolly Hagan
College of Nursing, New York University, New York, USA
Syst Rev 3:31. 2014..There is a need for systematic reviews and meta-analyses to synthesize the epidemiology, prevention and methods to control HCV infection in this population...
- Should benefit-risk assessment have its own drug "label"?R Scott Braithwaite
Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
Drug Healthc Patient Saf 3:37-41. 2011..Strengths, weaknesses, and feasibility challenges of this approach are discussed...
- Using value of information to guide evaluation of decision supports for differential diagnosis: is it time for a new look?R Scott Braithwaite
Department of Population Health, New York University School of Medicine, 550 First Avenue, VZ30 6th Floor, 615, New York, NY 10016, USA
BMC Med Inform Decis Mak 13:105. 2013..Decision support systems for differential diagnosis have traditionally been evaluated on the basis of criteria how sensitively and specifically they are able to identify the correct diagnosis established by expert clinicians...
- Effectiveness of smoking-cessation interventions for urban hospital patients: study protocol for a randomized controlled trialEllie Grossman
Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
Trials 13:126. 2012....
- Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?R Scott Braithwaite
Section on Value and Comparative Effectiveness, Department of Medicine, New York University School of Medicine, USA
J Int AIDS Soc 14:38. 2011..We estimated the incremental benefit and cost effectiveness of alternative monitoring strategies for east Africans with known HIV infection...
- Identifying favorable-value cardiovascular health servicesR Scott Braithwaite
Section of Value and Comparative Effectiveness, Division of General Internal Medicine, NYU School of Medicine, 423 E 23rd Street, New York, NY 10010, USA
Am J Manag Care 17:431-8. 2011..To identify cardiovascular health services with a high level of evidence to suggest that they deliver favorable value...
- Can life expectancy and QALYs be improved by a framework for deciding whether to apply clinical guidelines to patients with severe comorbid disease?R Scott Braithwaite
Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine New York, NY 10010, USA
Med Decis Making 31:582-95. 2011..e., do not apply a guideline if a patient's life expectancy (LE) is shorter than when a guideline's cumulative incremental benefits first exceed its cumulative incremental harms), but its health impact is unclear...
- Could media reports include a standardized scale for quality of evidence?R Scott Braithwaite
Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine, New York, NY 10010, USA
J Gen Intern Med 26:543-5. 2011..I outline one possible step towards a solution: medical journals can embed quality of evidence ratings in article summaries and create incentives for inclusion of these ratings in lay media reports...
- Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?R Scott Braithwaite
New York University School of Medicine, New York, NY, USA
Value Health 13:535-42. 2010..Our objective is to estimate the minimum effectiveness required for ARV adherence interventions to deliver acceptable value...
- Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation modelR Scott Braithwaite
Section of Value and Comparative Effectiveness, New York University School of Medicine, New York, New York, United States of America
PLoS Med 7:e1000234. 2010..Value-based insurance design (VBID) has been proposed to encourage essential care while controlling health expenditures. Our objective was to estimate the impact of broader diffusion of VBID on US health care benefits and costs...
- A study of financial incentives to reduce plasma HIV RNA among patients in careSteven Farber
Department of Medicine, Connecticut VA Healthcare System, West Haven, CT, USA
AIDS Behav 17:2293-300. 2013..It is feasible to use financial incentives to reward ART adherence, and to specify the incentive by requiring cost-neutrality and targeting biological outcomes. ..